EcoDrugPlus

Toll Like Receptor 2

Ensembl ID : ENSDNOG00000039179
Gene Symbol: TLR2
4 Cross references
249 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSDNOG00000032753
Gene Symbol: TLR4
4 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSDNOG00000034029
Gene Symbol: TLR7
2 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSDNOG00000036980
Gene Symbol: TLR8
4 Cross references
199 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSDNOG00000010413
Gene Symbol: TAAR1
4 Cross references
600 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSDNOG00000036661
Gene Symbol: TGFBR1
4 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSDNOG00000005728
Gene Symbol: TRPA1
2 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSDNOG00000008830
Gene Symbol: TRPM8
4 Cross references
158 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSDNOG00000031060
Gene Symbol: TSPO
4 Cross references
122 Possible Orthologues:

Transthyretin

Ensembl ID : ENSDNOG00000033960
Gene Symbol: TTR
4 Cross references
166 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSDNOG00000037660
Gene Symbol: TPH1
4 Cross references
257 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSDNOG00000014145
Gene Symbol: TUBA4A
4 Cross references
225 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).